BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17304504)

  • 1. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin.
    Retzer-Lidl M; Schmid RM; Schneider G
    Int J Cancer; 2007 Jul; 121(1):66-75. PubMed ID: 17304504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
    Han Y; Park S; Kinyua AW; Andera L; Kim KW; Kim I
    Oncol Rep; 2014 Jan; 31(1):456-62. PubMed ID: 24213797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
    Tanaka R; Tomosugi M; Horinaka M; Sowa Y; Sakai T
    PLoS One; 2015; 10(5):e0125779. PubMed ID: 25955843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
    Harashima N; Takenaga K; Akimoto M; Harada M
    Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
    Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM; Radulovich N; Ho J; Tsao MS
    Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of TRAIL-induced apoptosis in resistant human pancreatic cancer cells by a novel FAK inhibitor, PH11.
    Dao P; Smith N; Scott-Algara D; Garbay C; Herbeuval JP; Chen H
    Cancer Lett; 2015 Apr; 360(1):48-59. PubMed ID: 25684663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A moderate static magnetic field enhances TRAIL-induced apoptosis by the inhibition of Cdc2 and subsequent downregulation of survivin in human breast carcinoma cells.
    Lin T; Wan L; Qi X; Shi W; Lin J
    Bioelectromagnetics; 2014 Jul; 35(5):337-46. PubMed ID: 24619849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
    Lu M; Kwan T; Yu C; Chen F; Freedman B; Schafer JM; Lee EJ; Jameson JL; Jordan VC; Cryns VL
    J Biol Chem; 2005 Feb; 280(8):6742-51. PubMed ID: 15569667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
    Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
    Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells.
    Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y
    Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J; Lee YJ
    Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
    Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKP2 confers resistance of pancreatic cancer cells towards TRAIL-induced apoptosis.
    Schüler S; Diersch S; Hamacher R; Schmid RM; Saur D; Schneider G
    Int J Oncol; 2011 Jan; 38(1):219-25. PubMed ID: 21109943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.
    Song J; Cao L; Li Y
    Mol Med Rep; 2013 May; 7(5):1651-5. PubMed ID: 23467576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole.
    Goda AE; Yoshida T; Horinaka M; Yasuda T; Shiraishi T; Wakada M; Sakai T
    Oncogene; 2008 May; 27(24):3435-45. PubMed ID: 18193086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.